Dempze Nancy E Edwards Lifesciences Corp Transaction History

Dempze Nancy E

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $16,282 - $18,866	200 Added 7.18%	2,985 $281,000
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $206,814 - $235,360	2,785 New	2,785 $230,000
Q3 2022 Nov 08, 2022	SELL	$82.37 - $107.29 $39,702 - $51,713	-482 Reduced 15.22%	2,685 $222,000
Q2 2022 Jul 19, 2022	BUY	$86.5 - $128.27 $89,960 - $133,400	1,040 Added 48.9%	3,167 $301,000
Q1 2022 May 17, 2022	BUY	$101.96 - $128.34 $48,634 - $61,218	477 Added 28.91%	2,127 $250,000
Q4 2021 Feb 08, 2022	BUY	$106.37 - $130.68 $175,510 - $215,622	1,650 New	1,650 $214,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Dempze Nancy E, based on Form 13F filings with the SEC.

Stay updated on Dempze Nancy E with notifications on news.